Burgos
Universidad
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Institut d'Investigació Biomédica de Bellvitge (14)
2024
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma
Pharmaceutics, Vol. 15, Núm. 1
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
-
Small molecule anion carriers facilitate lactate transport in model liposomes and cells
iScience, Vol. 26, Núm. 10
2022
-
A Novel Late-Stage Autophagy Inhibitor That Efficiently Targets Lysosomes Inducing Potent Cytotoxic and Sensitizing Effects in Lung Cancer
Cancers, Vol. 14, Núm. 14
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Epigenome-wide association study of COVID-19 severity with respiratory failure
EBioMedicine, Vol. 66
2019
-
Targeting autophagy for cancer treatment and tumor chemosensitization
Cancers, Vol. 11, Núm. 10
-
The natural-based antitumor compound T21 decreases survivin levels through potent stat3 inhibition in lung cancer models
Biomolecules, Vol. 9, Núm. 8
-
Therapeutic strategies involving survivin inhibition in cancer
Medicinal Research Reviews, Vol. 39, Núm. 3, pp. 887-909
2017
-
Novel indole-based tambjamine-analogues induce apoptotic lung cancer cell death through p38 mitogen-activated protein kinase activation
Molecular Cancer Therapeutics, Vol. 16, Núm. 7, pp. 1224-1235
2009
-
Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer
Cancer Research, Vol. 69, Núm. 11, pp. 4926-4934